|4Sep 7, 5:45 PM ET

Wong Hing C 4

4 · HCW Biologics Inc. · Filed Sep 7, 2022

Insider Transaction Report

Form 4
Period: 2022-09-02
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2022-09-02$2.55/sh+4,000$10,20015,290,468 total
  • Purchase

    Common Stock

    2022-09-07$2.58/sh+6,000$15,48015,296,468 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION